Melita Jung
Corporate Officer/Principal bij TERNS PHARMACEUTICALS, INC.
Vermogen: - $ op 30-04-2024
Actieve functies van Melita Jung
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 22-04-2024 | - |
Loopbaan van Melita Jung
Eerdere bekende functies van Melita Jung
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01-07-2017 | 01-01-2021 |
| ADAMAS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-07-2014 | 01-06-2017 |
Ascendancy Healthcare, Inc.
 Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Ascendancy Healthcare, Inc. engages in the commercialization of pharmaceutical productS. It enables product entry by providing clinical, regulatory and commercial expertise and oversight along with funding. The company was founded by Arthur Joseph Higgins and Sanford S. Zweifach on November 21, 2011 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01-04-2012 | 01-05-2014 |
| STRUCTURE THERAPEUTICS INC. | Corporate Officer/Principal | 01-05-2021 | - |
Opleiding van Melita Jung
| University of California, Berkeley | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Corporate Officer/Principal | 5 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| TERNS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Ascendancy Healthcare, Inc.
Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Ascendancy Healthcare, Inc. engages in the commercialization of pharmaceutical productS. It enables product entry by providing clinical, regulatory and commercial expertise and oversight along with funding. The company was founded by Arthur Joseph Higgins and Sanford S. Zweifach on November 21, 2011 and is headquartered in San Francisco, CA. | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
- Beurs
- Insiders
- Melita Jung
- Ervaring
